Increase in patients suffering from cardiovascular diseases is expected to drive the growth of global ibuprofen market during the forecast period.
According to TechSci Research report, “Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Headache, dental pain, menstrual cramps, rheumatoid Arthritis, Ankylosing Spondylitis, Others), By End User (Hospitals, Clinics, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations (CMO), In-House), By Region, By Company, Competition, Forecast & Opportunities, 2026”, Global Ibuprofen market is expected to witness a steady growth over the forecast period. Rising awareness regarding rapid pain relief injections is one of the major factors accounting for the growth of global ibuprofen market. Moreover, occurrence of diverse range of diseases such as cardiovascular disease, diabetes, infectious diseases and kidney-related complications is expected to bode well for the growth of global ibuprofen market through the forecast period. In addition to this, increased development of innovative drugs by major pharmaceutical industries is positively influencing the growth of global Ibuprofen market in the years to come. Along with this, easy product availability coupled with extensive supply & distribution networks are positively contributing to the market growth in the next 5 years. However, there are certain factors that might act as major impediments to the growth of global Ibuprofen market during the forecast period such as various side effects of intravenous ibuprofen injections.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on“ Global Ibuprofen Market “
Global ibuprofen market can be segmented based on product type, route of administration, application, end user, age group, source, company, and region. Considering the application, the market is fragmented into headache, dental pain, menstrual cramps, rheumatoid arthritis, ankylosing spondylitis, others. The rheumatoid arthritis segment is anticipated to dominate the market during the forecast period which is accredited to application of this drug in treating rheumatoid arthritis or another type of inflammatory arthritis. Ibuprofen is as effective as aspirin and other nonsteroidal anti-inflammatory drugs when given at a dose of 1,200 mg/day to treat rheumatoid arthritis. The safety and tolerability of ibuprofen when compared to aspirin are superior, which is further estimated to drive the segmental growth over the coming years.
Mallinckordt Plc., Grifols S.A., BASF SE, Perrigo Company Plc., CSL Limited, Biotechnica Pharma International PTE Ltd., Harbin Gloria Pharmaceuticals Co., Ltd., Rochem International Inc., Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., among others are the leading players operating in global ibuprofen market. The leading players are adopting several growth strategies to enhance the market scenario of Ibuprofen. Other competitive strategies include product launches; mergers & acquisitions; agreements, partnerships, and research collaborations; and expansions to diverse their product portfolio in order to strengthen their market position.
Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=7235
customers can also request for 10% free customization on this report.
North America is forecasted to dominate the global ibuprofen market in the next 5 years on account of lifestyle changes and increasing healthcare expenditure. Asia pacific region is forecasted to register highest growing CAGR over the years to come which can be attributed to an increase in people in the elderly age group. Additionally, China is the largest supplier of Ibuprofen, contributing about 48% of market share and India is the second largest supplier of Ibuprofen. This is further expected to boost the market share.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Headache, dental pain, menstrual cramps, rheumatoid Arthritis, Ankylosing Spondylitis, Others), By End User (Hospitals, Clinics, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations (CMO), In-House), By Region, By Company, Competition, Forecast & Opportunities, 2026” has evaluated the future growth potential of global ibuprofen market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global ibuprofen market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017